A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Spain- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Spain572 clinical trials in A Coruna Galicia, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atherosclerotic cardiovascular disease prevention are currently underway. These studies aim to evaluate new therapeutic approaches for reducing major adverse cardiovascular events in high-risk patients.
The research emphasizes preventive strategies for patients at high risk of developing cardiovascular complications, including heart attacks, strokes, and conditions requiring urgent coronary procedures.
Tell us about your condition – we search every trial in Europe and connect you with the right site.